Extending the Time for Thrombolysis in Emergency Neurological Deficits — Intra-Arterial | Clinical Trial - EXTEND-IA


The goal of the trial was to compare the role of endovascular therapy as an adjunct to intravenous (IV) thrombolysis in patients presenting with acute ischemic stroke within 4.5 hours of symptom onset, compared with IV thrombolysis alone.

Contribution to the Literature: The EXTEND-IA study suggests that endovascular therapy is superior in improving perfusion, neurological, and functional outcomes compared with IV thrombolysis alone in eligible patients presenting with acute ischemic st...